About us
The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients.
Projects
Participation
Events
Press
Contact
Breadcrumbs
Last updated 07.07.2017
Project no.: D15-01
Commission: Commission awarded on 29.10.2015 by the Federal Joint Committee (G-BA).
Report type: Report
Status: Commission completed
Department/Division: Non-Drug Interventions
Application field: Head and nerves
Extract of the final report: Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema
published on Jul 7, 2017
Final report: Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema
Documentation and evaluation of comments on the preliminary report: Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema
Preliminary report: Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema
published on Nov 18, 2016
Report plan version 1.0: Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema
published on Jun 29, 2016
Documentation and evaluation of comments on the preliminary report plan: Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema
Preliminary report plan: Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema
published on Apr 5, 2016
Press contact
+49 221 356850
presse@iqwig.de
Info Service (German)
Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.
Contact form
Questions about commissions, publications and press releases can be sent to us via this form.
